Anebulo Pharmaceuticals Inc

Company Snapshot
1017 Ranch Road 620 South
Lakeway, TX 78734
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 3
https://www.anebulo.com
Please select from the dropdown
  1. Executive Compensation
  2. > Anebulo Pharmaceuticals Inc
Company Financials

2022
2023
2024
Gross Profit
Operating Income
-$6,831,174
-$11,783,599
-$8,308,755
Net Income
-$6,825,619
-$11,732,338
-$8,201,703
2022
Gross Profit
Operating Income
-$6,831,174
Net Income
-$6,825,619
2023
Gross Profit
Operating Income
-$11,783,599
Net Income
-$11,732,338
2024
Gross Profit
Operating Income
-$8,308,755
Net Income
-$8,201,703
The above data on Anebulo Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Richard Cunningham
Chief Executive Officer and Director
$332,885
$1,367,325
$0
$1,700,210
Richard Cunningham
$1,700,210
Chief Executive Officer and Director
Kenneth Cundy
Chief Scientific Officer
$492,756
$119,395
$0
$612,151
Kenneth Cundy
$612,151
Chief Scientific Officer
Daniel George
Chief Financial Officer and Principal Accounting Officer
$147,268
$0
$0
$147,268
Daniel George
$147,268
Chief Financial Officer and Principal Accounting Officer
Bimal Shah
Independent Director
$8,101
$116,430
$0
$124,531
Bimal Shah
$124,531
Independent Director
Jason Aryeh
Independent Director
$16,000
$67,236
$0
$83,236
Jason Aryeh
$83,236
Independent Director
Anebulo Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2024. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us